Trial of Intensive Blood-Pressure Control in Older Patients with Hypertension
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Background The appropriate target for systolic blood pressure to reduce cardiovascular risk in older patients with hypertension remains unclear. Methods In this multicenter, randomized, controlled trial, we assigned Chinese patients 60 to 80 years of age with hypertension to a systolic blood-pressure target of 110 to less than 130 mm Hg (intensive treatment) or a target of 130 to less than 150 mm Hg (standard treatment). The primary outcome was a composite of stroke, acute coronary syndrome (acute myocardial infarction and hospitalization for unstable angina), acute decompensated heart failure, coronary revascularization, atrial fibrillation, or death from cardiovascular causes. Results Of the 9624 patients screened for eligibility, 8511 were enrolled in the trial; 4243 were randomly assigned to the intensive-treatment group and 4268 to the standard-treatment group. At 1 year of follow-up, the mean systolic blood pressure was 127.5 mm Hg in the intensive-treatment group and 135.3 mm Hg in the standard-treatment group. During a median follow-up period of 3.34 years, primary-outcome events occurred in 147 patients (3.5%) in the intensive-treatment group, as compared with 196 patients (4.6%) in the standard-treatment group (hazard ratio, 0.74; 95% confidence interval [CI], 0.60 to 0.92; P = 0.007). The results for most of the individual components of the primary outcome also favored intensive treatment: the hazard ratio for stroke was 0.67 (95% CI, 0.47 to 0.97), acute coronary…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial included nearly 20% of people with diabetes and noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (39).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [39]
In the citing paper
“Participants with diabetes comprised nearly 20% of the Strategy of Blood Pressure Intervention in the Elderly Hypertensive Patients (STEP) trial, which noted decreased cardiovascular events with treatment of hypertension to a systolic blood pressure goal of <130 mmHg (41).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [41]
In the citing paper
“Hypotension occurred more frequently in the intensive treatment group (3.4%) compared with the standard treatment group (2.6%), without signi fi cant differences in other adverse events, including dizziness, syncope, or fractures.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, the primary composite outcome of stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fi brillation, or death from cardiovascular causes was reduced by 26% in the intensive treatment group.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
In the citing paper
“In this trial, 18.9% of patients in the intensive treatment arm and 19.4% in the standard treatment arm had a diagnosis of type 2 diabetes.”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2023 (2023) · cites this paper as [34]
Citations
Cites
A Proportional Hazards Model for the Subdistribution of a Competing Risk
Fine, J. P., & Gray, R. J. (1999) · Journal of the American Statistical Association · doi:10.1080/01621459.1999.10474144 · Cited by 14,290
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
2018 ESC/ESH Guidelines for the management of arterial hypertension
Williams, B., Mancia, G., Spiering, W., Agabiti Rosei, E., Azizi, M., Burnier, M., Clement, D. L., Coca, A., de Simone, G., Dominiczak, A., et al. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy339 · Cited by 10,286
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Hypertension · doi:10.1161/hyp.0000000000000065 · Cited by 7,391
Whelton, P. K., Carey, R. M., Aronow, W. S., Casey, D. E., Collins, K. J., Dennison Himmelfarb, C., DePalma, S. M., Gidding, S., Jamerson, K. A., Jones, D. W., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.11.006 · Cited by 6,616
2020 International Society of Hypertension Global Hypertension Practice Guidelines
Unger, T., Borghi, C., Charchar, F., Khan, N. A., Poulter, N. R., Prabhakaran, D., Ramirez, A., Schlaich, M., Stergiou, G. S., Tomaszewski, M., et al. (2020) · Hypertension · doi:10.1161/hypertensionaha.120.15026 · Cited by 4,132
Ettehad, D., Emdin, C. A., Kiran, A., Anderson, S. G., Callender, T., Emberson, J., Chalmers, J., Rodgers, A., & Rahimi, K. (2016) · The Lancet · doi:10.1016/s0140-6736(15)01225-8 · Cited by 3,755
Effects of intensive blood-pressure control in type 2 diabetes mellitus
(2010) · New England Journal of Medicine · doi:10.1056/nejmoa1001286 · Cited by 3,598
Treatment of hypertension in patients 80 years of age or older
Beckett, N. S., Peters, R., Fletcher, A. E., Staessen, J. A., Liu, L., Dumitrascu, D., Stoyanovsky, V., Antikainen, R. L., Nikitin, Y., Anderson, C., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0801369 · Cited by 3,092
Cited by
Items 301–400 of 805
Blood Pressure and Heart Rate Management in Patients After Repair of Type A Aortic Dissection
Ho, C.-H., Lin, C., Chang, F.-C., Chen, C.-Y., Cheng, Y., Tung, Y., Chan, Y., Wu, V. C., Chu, P., & Chen, S. (2025) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2025.02.012 · Cited by 6
Liao, C., Toh, H. S., Yang, C., Hsu, C., Lee, M.-C., Chang, W., Chen, Z., Chang, H., & Strong, C. (2022) · Hypertension Research · doi:10.1038/s41440-022-01037-5 · Cited by 6
Song, Q., Ling, Q., Bai, J., Zhang, H., Bu, P., Chen, F., Wu, S., Zhang, W., Chen, M., & Cai, J. (2022) · BMC Medicine · doi:10.1186/s12916-022-02556-1 · Cited by 6
Self-citationXu, W., Song, Q., Zhang, H., Wang, J., Shao, X., Wu, S., Zhu, J., Cai, J., & Yang, Y. (2023) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002627 · Cited by 6
Self-citationYang, R., Zhu, Y., Xu, M., Tao, Y., Cong, W., & Cai, J. (2023) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwad105 · Cited by 6
Self-citationEnnezat, P. V., Alavi, Z., Jemtel, T. H. L., & Hansen, M. R. (2022) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000001215 · Cited by 6
Li, C., Wang, C., Hao, J., Zheng, Y., Yang, J., Wang, W., & Tang, Y. (2023) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2023.100773 · Cited by 6
Self-citationThe Potential Impact of the 2022 ESC Cardio-Oncology Guidelines on Clinical Practice in China
Tse, G., Shao, Q., Liu, J., & Zhang, Y. (2023) · JACC CardioOncology · doi:10.1016/j.jaccao.2023.01.003 · Cited by 6
The importance of regular home blood pressure monitoring over the life course
Tomitani, N., Hoshide, S., & Kario, K. (2023) · Hypertension Research · doi:10.1038/s41440-023-01492-8 · Cited by 6
Self-citationKario, K., Hoshide, S., & Mogi, M. (2024) · Hypertension Research · doi:10.1038/s41440-024-01927-w · Cited by 7
Self-citationLiu, H., Wang, Y., Zhang, B., Liu, J., Huo, Y., Cao, S., Wu, S., Wan, Y., Xie, X., Zeng, L., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1157327 · Cited by 7
Self-citationLi, W., Lian, R., Li, Y., Lian, X., Dai, Z., Zhong, Z., Shi, W., Wang, Y., Chen, W., Li, J., et al. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf017 · Cited by 5
Self-citationImpact of antihypertensive drug classes on cardiovascular outcomes: insights from the STEP study
Peng, X., Olsen, M. H., Pareek, M., Bai, J., Liu, Y., Song, Q., & Cai, J. (2025) · BMC Medicine · doi:10.1186/s12916-025-04158-z · Cited by 5
Self-citationPark, S., Shin, E.-S., Ihm, S., & Lee, H. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e25 · Cited by 7
Dong, X., Bai, J., Ling, Q., Zhao, X., & Cai, J. (2025) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwaf507 · Cited by 5
Self-citationSmith, K. C., Gaziano, T. A., Mushlin, A. I., Cutler, D., Menzies, N. A., & Pandya, A. (2025) · Annals of Internal Medicine · doi:10.7326/annals-25-00560 · Cited by 5
Fu, Z., Song, S., Ji, Y., Duan, L., Wang, Z., Chen, Y., Guo, Y., Zhao, K., Xu, X., Wang, C., et al. (2025) · The Journals of Gerontology Series A · doi:10.1093/gerona/glaf273 · Cited by 6
Self-citationOptimal Medical Therapy for Stable Ischemic Heart Disease in 2024
Abrahams, T., Nicholls, S. J., & Nelson, A. J. (2024) · Medical Clinics of North America · doi:10.1016/j.mcna.2023.12.005 · Cited by 5
Pharmacologic Treatment of Hypertension in Older Adults
Todd, O. M., Knight, M., Jacobs, J. A., Derington, C. G., Sheppard, J. P., & Bress, A. P. (2024) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2024.04.004 · Cited by 5
Suzuki, Y., Kaneko, H., Okada, A., Fujiu, K., Takeda, N., Morita, H., Yano, Y., Nishiyama, A., Node, K., Yasunaga, H., et al. (2024) · Journal of Cardiology · doi:10.1016/j.jjcc.2024.07.005 · Cited by 5
Pan, H., Yang, P.-L., Lin, C.-H., Chi, C.-Y., Lu, C., Lai, T., Yeh, C., Chen, M. Y., Wang, T., Kao, H., et al. (2024) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2024.09.023 · Cited by 5
Self-citationVery low SBP targets and the boom-and-bust cycle of benefit and adverse kidney events
Fernández‐Fernández, B., Valdivielso, J. M., Chinnappa, S., Sarafidis, P. A., & Ortíz, A. (2025) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfaf053 · Cited by 5
Zhang, Y., Yang, S., Wang, S., Zou, X., Tang, L., Chen, L., Ma, J., Li, Y., Yao, T., Zhang, X., et al. (2025) · Neurology · doi:10.1212/wnl.0000000000213545 · Cited by 6
Self-citationBaseline risk and outcome benefit from intensive blood pressure targeting. A systematic review
Verdecchia, P., Angeli, F., & Reboldi, G. (2025) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2025.07.005 · Cited by 5
Penko, J. M., Bellows, B. K., Hennessy, S., Kazi, D. S., Boylan, R. D., Zhang, Y., Coxson, P. G., Goldman, L., Bibbins-Domingo, K. B., & Moran, A. E. (2025) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.124.011872 · Cited by 6
Shin, J., & Kim, K. (2022) · Clinical Hypertension · doi:10.1186/s40885-022-00202-9 · Cited by 5
The role of blood pressure management in stroke prevention: current status and future prospects
Narita, K., Hoshide, S., & Kario, K. (2022) · Expert Review of Cardiovascular Therapy · doi:10.1080/14779072.2022.2137490 · Cited by 6
Self-citationWan, J., Liu, G., Xia, S., Liu, S., Yang, Y., Wang, D., Hou, J., Dai, X., Zhou, P., & Wang, P. (2022) · Therapeutic Advances in Chronic Disease · doi:10.1177/20406223221135011 · Cited by 5
Qiu, Y., Ma, J., Zhu, J., Liu, Y., Ren, W., Zhang, S., & Ren, J. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1080682 · Cited by 6
Self-citationBénétos, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-88369-6.00045-1 · Cited by 6
Zhang, K., Song, Q., Bai, J., & Cai, J. (2024) · Hypertension Research · doi:10.1038/s41440-024-01647-1 · Cited by 5
Self-citationSerum Endocan Is a Risk Factor for Aortic Stiffness in Patients Undergoing Maintenance Hemodialysis
Wu, T.-J., Wang, C., Lai, Y., Kuo, C., Lin, Y., & Hsu, B. (2024) · Medicina · doi:10.3390/medicina60060984 · Cited by 5
Drug-gene interactions in older patients with coronary artery disease
Zhang, S., Lv, C., Dong, L., Wu, Y., & Yin, T. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05471-7 · Cited by 5
Self-citationHassanein, M. M., Akbar, M. A. J., Alshamiri, M. Q., Amir, A., Amod, A., Chudleigh, R. A., Elhadd, T. A., Heshmat, H., Jibani, M. M., & Saleh, Y. M. A. (2022) · Diabetes Therapy · doi:10.1007/s13300-022-01282-4 · Cited by 5
Atherosclerosis risk factor management - what's new for the neurologist?
Bichuette, L. D., Lottenberg, M. P., Cardozo, F. A. M., & Calderaro, D. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1590/0004-282x-anp-2022-s102 · Cited by 5
Kaneko, H., Yano, Y., Suzuki, Y., Okada, A., Itoh, H., Matsuoka, S., Fujiu, K., Michihata, N., Jo, T., Takeda, N., et al. (2022) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwac193 · Cited by 5
Daily exercise improves the long-term prognosis of patients with acute coronary syndrome
Hu, Q., Li, P.-X., Li, Y., Ren, Q., Zhang, J., Liang, Y., Zhang, Q., & Han, Y. (2023) · Frontiers in Public Health · doi:10.3389/fpubh.2023.1126413 · Cited by 5
Self-citationStep for breaking free from clinical inertia
Rakugi, H. (2021) · Hypertension Research · doi:10.1038/s41440-021-00767-2 · Cited by 5
Kim, H., Lee, Y., Shin, J., Kim, J. H., Hwang, S. H., Kim, W.-S., Park, S., Rhee, S. J., Lee, E. M., Ihm, S., et al. (2025) · Journal of Korean Medical Science · doi:10.3346/jkms.2025.40.e117 · Cited by 4
Kim, B. S., Lim, Y., Shin, J., & Shin, J. (2025) · Clinical Hypertension · doi:10.5646/ch.2025.31.e13 · Cited by 4
Guo, J., Liu, Y., Liu, X., Yan, M., Zhang, Y., Fang, S., Wang, S., & Yu, B. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101678 · Cited by 4
Faconti, L., Tantirige, N. N. T., Poulter, N. R., George, J., Kapil, V., Gupta, A. K., Swift, P. A., Heagerty, A. M., Shantsila, E., Partridge, S., et al. (2025) · Journal of Human Hypertension · doi:10.1038/s41371-025-01055-z · Cited by 4
Cardiomyopathy in Older Adults
O’Neill, D. E., & Forman, D. E. (2025) · Current Cardiology Reports · doi:10.1007/s11886-025-02306-8 · Cited by 5
Risk management of cardiovascular disease in older patients with diabetes
Sawami, K., Tanaka, A., & Node, K. (2025) · Hypertension Research · doi:10.1038/s41440-025-02424-4 · Cited by 4
Choi, S., Han, K., Yu, K., Lee, B., Oh, M. S., Cheon, D. Y., & Lee, M. (2026) · European Journal of Preventive Cardiology · doi:10.1093/eurjpc/zwag024 · Cited by 5
Chinese guidelines for diagnosis and treatment of intracranial atherosclerotic stenosis
Leng, X., Sui, B., Liu, C., Wang, T., Li, M. L., Tian, X., Liu, Y., Song, B., Sun, Q., Wang, H., et al. (2026) · International Journal of Stroke · doi:10.1177/17474930261419812 · Cited by 4
Self-citationTarget systolic blood pressure in patients with left ventricular hypertrophy
Kjeldsen, S. E., Egan, B. M., Mancia, G., Mariampillai, J. E., Heimark, S., & Burnier, M. (2026) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2026.106760 · Cited by 6
Blood Pressure Trajectories and Cardiovascular Outcomes in Older Patients
Peng, X., Song, Q., Bai, J., Liu, Y., Cui, F., Chen, Z., & Cai, J. (2026) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2026.01.090 · Cited by 4
Self-citationWang, X., & Cai, J. (2022) · Chinese Medical Journal · doi:10.1097/cm9.0000000000002236 · Cited by 4
Self-citationWang, C., Liu, S., Miao, W., Ye, N., Xie, Z., Qiao, L., Ouyang, N., Yin, Y., Sun, Y., & Sun, G. (2024) · The Lancet Regional Health - Western Pacific · doi:10.1016/j.lanwpc.2024.101127 · Cited by 8
“16 China Rural Hypertension Control Project (CRHCP), an implementation study testing safety and effective of intensive BP strategy with a target of 130/80 mmHg, enrolled a general population, having high representativeness.”
BackgroundSelf-citationBaracaldo-Campo, H. A., Cadena-Sanabria, M. O., & Gómez, S. E. S. (2024) · Medunab · doi:10.29375/01237047.4695 · Cited by 4
Wang, N., Chalmers, J. P., Harris, K., Poulter, N. R., Mancia, G., Harrap, S. B., Hamet, P., Grobbee, D. E., Marre, M., & Woodward, M. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003855 · Cited by 5
Hu, Z., Luo, D., Zhou, W., Xu, C., Chen, X.-Z., Zhang, B., Jin, X., Wang, Y., Zhang, J., Wu, H. M., et al. (2024) · BMC Cardiovascular Disorders · doi:10.1186/s12872-024-04168-4 · Cited by 4
Self-citationSoh, M.-S., Won, K.-H., Kim, J., Lee, S. Y., Hyon, M. S., Youn, H., Rha, S., Kim, D., Ahn, Y., Kim, B. J., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-74003-5 · Cited by 8
A brief approach to hypertension in type 2 diabetes mellitus
Güneş, Y. (2025) · Exploration of Endocrine and Metabolic Diseases · doi:10.37349/eemd.2025.101422 · Cited by 10
Li, B. (2025) · Journal of Community Health Nursing · doi:10.1080/07370016.2025.2462006 · Cited by 6
“In China, researchers have identified similar issues, noting that generalized health advice often fails to meet the needs of patients from diverse socioeconomic backgrounds (W. Zhang et al., 2021), especially in rapidly urbanizing areas like Shenzhen.”
Oguri, M., Ishii, H., Fujikawa, Y., Maeda, S., Shigematsu, T., Takahashi, H., Amano, T., & Murohara, T. (2025) · Circulation Journal · doi:10.1253/circj.cj-24-0653 · Cited by 2
Ling, Q., Dong, X., Zhao, X., & Cai, J. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101675 · Cited by 5
Self-citationShu, J., Xie, C., Gao, L., Wang, Z., Ren, Q., Jin-hai, S., & Yuan, L. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-087905 · Cited by 5
Sun, G., Miao, W., Liu, S., Yin, Y., Geng, D., Ye, N., Xie, Z., Zhang, L., Zhou, S., Wang, C., et al. (2025) · JAMA Network Open · doi:10.1001/jamanetworkopen.2025.19604 · Cited by 4
Self-citationHuang, X., Zhang, H., Li, Y., Ge, J., Sun, Y. H., Zhang, L., Zhao, L., Liu, J., Zhang, C., Du, J., et al. (2025) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2025.06.010 · Cited by 4
Self-citationManaging stage 1 hypertension: Consider the risks, stop the progression
Hooker, A., BUDA, K. G., & Pasha, M. (2022) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.89a.21101 · Cited by 5
Yang, R., Wang, Y., Tong, A., Yu, J., Zhao, D., & Cai, J. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.04.019 · Cited by 5
Self-citationYang, R., Huang, R., Zhang, L., Li, D., Luo, J., & Cai, J. (2023) · Hypertension · doi:10.1161/hypertensionaha.123.21892 · Cited by 4
Self-citationRyu, S. I., Lee, S. H., Byoun, H. S., Kim, Y., Bang, J. S., Bang, J. S., Kwon, O.-K., Oh, C. W., & Lee, S. U. (2024) · Journal of Clinical Neuroscience · doi:10.1016/j.jocn.2024.03.004 · Cited by 5
Systolic Blood Pressure and Survival to Very Old Age: Results From the Women’s Health Initiative
Haring, B., Andrews, C., Hovey, K. M., Shadyab, A. H., LaCroix, A. Z., Martin, L. W., Rosal, M. C., Kuller, L. H., Salmoirago‐Blotcher, E., Saquib, N., et al. (2024) · Circulation · doi:10.1161/circulationaha.123.067302 · Cited by 5
Weijs, R. W. J., de Roos, B. M., Thijssen, D. H. J., & Claassen, J. A. H. R. (2024) · GeroScience · doi:10.1007/s11357-024-01174-4 · Cited by 6
Elevated blood pressure and hypertension in older persons: A comment on the recent ESC guidelines
Rivasi, G., Brunetti, E., Presta, R., Marchionni, N., Desideri, G., & Bo, M. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.10.013 · Cited by 4
Effect of Combination Antihypertensive Pills on Blood Pressure Control
Heaton, J. N., Johal, A. S., Alshami, A., Okoh, A. K., Udongwo, N., Schoenfeld, M. S., Saybolt, M. D., Almendral, J. G., & Sealove, B. A. (2024) · Journal of the American Heart Association · doi:10.1161/jaha.124.036046 · Cited by 4
Li, C., Hsueh, S., Tsai, L., Chang, W. H., Cheng, S., Cheng, H., Yeh, C., Lin, Y.-H., & Tsai, H.-H. C. (2025) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2025.01.008 · Cited by 5
Complexities in Geriatric Cardiology: Clinical Dilemmas and Gaps in Evidence
Theodorakis, N., Hitas, C., Vamvakou, G. D., Kalantzi, S., Spyridaki, A., Kollia, Z., Feretzakis, G., & Nikolaou, M. (2025) · 老年心脏病学杂志:英文版 · doi:10.26599/1671-5411.2025.01.004 · Cited by 5
Huo, Z., Wu, S., Li, L., Zhang, J., Liu, Y., Han, X., Chen, S., Wang, G., Li, C., Zhang, S., et al. (2025) · JACC Advances · doi:10.1016/j.jacadv.2025.101702 · Cited by 5
Self-citationMousavi, A., Shojaei, S., Abhari, A. P., Mirhosseini, S. A., Ebrahimi, R., Rajabi, E., Farooqi, M. A., Azizpour, A., Moghadam, S. A., Kuno, T., et al. (2025) · American Journal of Hypertension · doi:10.1093/ajh/hpaf140 · Cited by 5
Huang, X., Ye, J., Liu, S., Xu, Z., Pan, M., Lin, J., & Xie, L. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70114 · Cited by 4
Updates in hypertension: new trials, targets and ways of measuring blood pressure
Salman, L. A., & Cohen, J. B. (2022) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000000791 · Cited by 4
How low should blood pressure be in patients with chronic coronary and cerebrovascular diseases
Manolis, A. J., Kallistratos, M. S., Camafort, M., & Coca, A. (2023) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2023.01.007 · Cited by 4
Shim, H. S., Park, J.-M., Lee, Y. J., Kim, Y.-D., Kim, T., Ban, S. P., Bang, J. S., Kwon, O.-K., Oh, C. W., & Lee, S. U. (2023) · Frontiers in Neurology · doi:10.3389/fneur.2023.1268542 · Cited by 6
Lee, J. J., & Lee, K. H. (2024) · JMIR Public Health and Surveillance · doi:10.2196/52182 · Cited by 8
Jiang, C., Wang, Z., Du, X., Wang, Y., Gao, M., Jia, Z., Chai, Z., Yang, Z., Wang, C., He, L., et al. (2024) · American Heart Journal · doi:10.1016/j.ahj.2024.08.008 · Cited by 4
Liu, Y., Su, W., Lin, C.-Y. G., Tsai, C., Su, H., & Chen, S. (2025) · Journal of Clinical Hypertension · doi:10.1111/jch.70013 · Cited by 4
Goupil, R., Tsuyuki, R. T., Santesso, N. A., Terenzi, K. A., Habert, J., Cheng, G., Gysel, S. C., Bruneau, J., Leung, A. A. C., Campbell, N. R. C., et al. (2025) · Canadian Pharmacists Journal / Revue des Pharmaciens du Canada · doi:10.1177/17151635251343907 · Cited by 3
Ji, Y., Peng, X., Chen, S., Song, Q., Bai, J., & Cai, J. (2025) · Hypertension Research · doi:10.1038/s41440-025-02349-y · Cited by 3
Self-citationFujiwara, T., Koshiaris, C., Cai, T., Wang, A., Lee, J. J., Lay-Flurrie, S. L., Banerjee, A., Clegg, A. P., Payne, R., Swain, S., et al. (2025) · PLoS Medicine · doi:10.1371/journal.pmed.1004731 · Cited by 4
“…beneficial effects for cerebral blood flow [17,18], but there is no definitive evidence to date for benefit from antihypertensive therapy on CVD outcomes in individuals with dementia [51,52], because most trial participants were relatively fit, people with dementia were excluded by design [4,5,53].”
Self-citationJiang, Y., Qu, H., Guo, H., Guo, M., Liang, J., Niu, Y., Chen, L., Wang, X., Li, Y., Jiang, H., et al. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157315 · Cited by 3
Self-citationDaemen, J., Saville, K. A., Ryschon, A. M., Cao, K. N., van Kuijck, J., Spiering, W., & Pietzsch, J. B. (2025) · Blood Pressure · doi:10.1080/08037051.2025.2573034 · Cited by 3
Peng, Y., Xia, F., Shao, Z., Pala, S., Yue, W., Ding, H., Xie, J., & Lin, L. (2025) · Microsystems & Nanoengineering · doi:10.1038/s41378-025-01019-w · Cited by 3
Mills, K. T., Ferguson, T., López-López, J., Duncan, J. D., Lanza, P., Marshall, A. N., Reyes, M. M., Chen, J., Anderson, A. H., Whelton, P. K., et al. (2025) · American Heart Journal · doi:10.1016/j.ahj.2025.107329 · Cited by 3
2024 Thai guidelines on the treatment of hypertension
Kunanon, S., Kotruchin, P., Chattranukulchai, P., Chotruangnapa, C., Roubsanthisuk, W., Vathesatogkit, P., Kunavisarut, T., Silaruks, S., Tejavanija, S., Wataganara, T., et al. (2025) · Asian Biomedicine · doi:10.2478/abm-2025-0034 · Cited by 3
Barac, A., Guha, A., Fleming, T. R., Bonaca, M. P., Thavendiranathan, P., Deswal, A., Amiri‐Kordestani, L., Bhatnagar, V., Cordoba, R., Hurvitz, S., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001417 · Cited by 3
Gori, M., Marini, M., Gonzini, L., Carigi, S., Gennaro, L. D., Gentile, P., Leonardi, G., Orso, F., Tinti, M. D., Lucci, D., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11226627 · Cited by 3
Blood pressure and variability responses to the down-titration of antihypertensive drugs
Kim, B. S., Lee, Y., Shin, J., Heo, R., Kim, H., & Shin, J. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003668 · Cited by 3
Liu, X., Lin, B., Yao, S., & Pan, Z. (2024) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2501006 · Cited by 3
Tso, J., & Kim, J. H. (2024) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2023.09.004 · Cited by 3
Characteristics According to Frailty Status Among Older Korean Patients With Hypertension
Choi, J., Lee, H., Lee, J., Hong, Y., Park, S. K., Ryu, D. R., Lee, J. H., Hwang, S., Kim, K. H., Lee, S. H., et al. (2024) · Journal of Korean Medical Science · doi:10.3346/jkms.2024.39.e84 · Cited by 5
Nolde, J. M., Atkins, E., Marschner, S. L., Hillis, G. S., Chalmers, J. P., Billiot, L., Nelson, M. R., Reid, C. M., Hay, P. D., Burke, M., et al. (2024) · Journal of Hypertension · doi:10.1097/hjh.0000000000003683 · Cited by 3
East meets West: Bringing the ESH 2023 hypertension guidelines into Asia
Sukonthasarn, A., Borghi, C., Chan, Y. H., Cheng, F. C., Choi, H., Mehta, R., Le, B., Lim, I. H., Lin, T.-H., Rosman, A., et al. (2024) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2024.06.026 · Cited by 4
He, F., Zhou, Z., Zhao, S., Li, W., Lian, X., Yu, J., Lin, Z., Song, Z., Chen, W., & Li, J. (2024) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.25118 · Cited by 3
Li, Q., Xu, T., Hu, T., & Lou, Y. (2024) · International Journal of Technology Assessment in Health Care · doi:10.1017/s0266462324000461 · Cited by 3
Impact of intensive blood pressure control on kidney outcomes
Huang, J. X., Peschard, V.-G., & Ku, E. (2025) · Current Opinion in Nephrology & Hypertension · doi:10.1097/mnh.0000000000001070 · Cited by 3
Wu, S., Jiang, S., Yao, Y., & Li, M. (2025) · Coronary Artery Disease · doi:10.1097/mca.0000000000001545 · Cited by 4
Self-citation
Metadata
- Authors
- Zhang, W., Zhang, S., Deng, Y., Wu, S., Ren, J., Sun, G., Yang, J., Jiang, Y., Xu, X., Wang, T.-D., Chen, Y., Li, Y., Yao, L., Li, D., Wang, L., Shen, X., Yin, X., Liu, W., Zhou, X., Zhu, B., Guo, Z., Liu, H., Chen, X., Feng, Y., Tian, G., Gao, X., Kario, K., & Cai, J.
- Affiliations
- Shanxi Medical University (CN)
- Hebei North University (CN)
- Omron (Japan) (JP)
- Jichi Medical University (JP)
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2021-09-30
- Volume
- 385
- Issue
- 14
- Pages
- 1268-1279
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W3198533772
- Cited by
- 784
- References
- 47
- Citations by year
- 2026: 131 · 2025: 196 · 2024: 146 · 2023: 134 · 2022: 154 · 2021: 23
- FWCI
- 76.60
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (81630014, 81825002)
- Beijing Outstanding Young Scientist Program (BJJWZYJH01201910023029)
- Chinese Academy of Medical Sciences Innovation Fund for Medical Sciences (2016-I2M-1-006, CI2021A00920)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Blood Pressure and Hypertension Studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Disease Prevention
- Health Sciences › Nursing › Nutrition and Dietetics › Sodium Intake and Health
- Keywords
- intensive blood pressure control, systolic blood pressure target, older adults, hypertension, cardiovascular risk reduction, stroke, acute coronary syndrome, acute decompensated heart failure, coronary revascularization, atrial fibrillation, cardiovascular mortality, renal outcomes, antihypertensive therapy, Chinese patients, SPRINT trial
- MeSH terms
- Aged, Aged, 80 and over, Antihypertensive Agents, Blood Pressure, Cardiovascular Diseases, Female, Humans, Hypertension, Hypotension, Male, Middle Aged, Systole, Incidence, Standard of Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.